Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v3-EN
Language French English
Date Updated 2017-12-08 2017-05-05
Drug Identification Number 02368226 02368226
Brand name MYLAN-MONTELUKAST MYLAN-MONTELUKAST
Common or Proper name MONTELUKAST MONTELUKAST
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients MONTELUKAST MONTELUKAST
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30BL, 100BT 30
ATC code R03DC R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-01
Actual start date 2017-04-11
Estimated end date 2017-12-01 Unknown
Actual end date 2017-12-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments discontinued under ID 16145
Health Canada comments